EPS15L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.245400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.629200E-01
Normal-vs-Stage2
5.309800E-01
Normal-vs-Stage3
5.166200E-01
Normal-vs-Stage4
7.954800E-01
Stage1-vs-Stage2
1.365960E-01
Stage1-vs-Stage3
9.279400E-01
Stage1-vs-Stage4
2.666800E-01
Stage2-vs-Stage3
4.787000E-01
Stage2-vs-Stage4
7.552800E-01
Stage3-vs-Stage4
5.548400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.250800E-01
Normal-vs-AfricanAmerican
5.228200E-01
Normal-vs-Asian
6.594400E-01
Caucasian-vs-AfricanAmerican
8.875200E-01
Caucasian-vs-Asian
8.315600E-01
AfricanAmerican-vs-Asian
7.932400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.717600E-01
Normal-vs-Female
3.473400E-01
Male-vs-Female
1.403610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.888800E-01
Normal-vs-Age(41-60Yrs)
9.209600E-01
Normal-vs-Age(61-80Yrs)
3.783400E-01
Normal-vs-Age(81-100Yrs)
6.202800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.314200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.931000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.365600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.620900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.818600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.436200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.022800E-01
Normal-vs-Daily Drinker
4.864000E-01
Normal-vs-Weekly Drinker
6.144200E-01
Normal-vs-Occasional Drinker
7.650600E-01
Normal-vs-Social Drinker
6.623400E-01
Non Drinker-vs-Daily Drinker
8.767400E-01
Non Drinker-vs-Weekly Drinker
4.942200E-01
Non Drinker-vs-Occasional Drinker
1.750350E-01
Non Drinker-vs-Social Drinker
4.093800E-01
Daily Drinker-vs-Weekly Drinker
6.249000E-01
Daily Drinker-vs-Occasional Drinker
2.786000E-01
Daily Drinker-vs-Social Drinker
5.392200E-01
Weekly Drinker-vs-Occasional Drinker
5.848600E-01
Weekly Drinker-vs-Social Drinker
9.056800E-01
Occasional Drinker-vs-Social Drinker
6.812800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.284590E-01
Normal-vs-Grade 2
4.941400E-01
Normal-vs-Grade 3
5.095200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.959000E-01
Grade 1-vs-Grade 3
4.951200E-01
Grade 1-vs-Grade 4
1.284590E-01
Grade 2-vs-Grade 3
6.351400E-01
Grade 2-vs-Grade 4
4.941400E-01
Grade 3-vs-Grade 4
5.095200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.709200E-01
Normal-vs-NonDiabetic
5.561800E-01
Diabetic-vs-NonDiabetic
5.080200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.894600E-01
Normal-vs-NoPancreatitis
5.121000E-01
Pancreatitis-vs-NoPancreatitis
4.092000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.512400E-01
Normal-vs-N1
5.242000E-01
N0-vs-N1
7.172400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.557200E-01
Normal-vs-TP53-NonMutant
4.924800E-01
TP53-Mutant-vs-TP53-NonMutant
4.647200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
